Interferon-mediated Protein Kinase in Mouse Cells Treated with Iododeoxyuridine (IdUrd) and Induced to Express Endogenous Retroviruses

References

1. Aarronson S. A., Rowe W. P. 1970; Non producer clones of murine sarcoma virus transformed BALB/3T3 cells. Virology 42:9–19
   [Google Scholar]
2. Aaronson S. A., Stephenson J. R. 1975; Differential cellular regulation of three distinct classes of type C RNA viruses endogenous to mouse cells. Cold Spring Harbor Symposia on Quantitative Biology 39:1129–1138
   [Google Scholar]
3. Aaronson S. A., Weaver C. A. 1971; Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. Journal of General Virology 13:245–252
   [Google Scholar]
4. Barre-Sinoussi F., Montagnier L., Lidereau R., Sisman J., Wood J., Chermann J. C. 1979; Enhancement of retrovirus production by anti-interferon serum. Annales de Microbiologie (Institut Pasteur) 130b:349–362
   [Google Scholar]
5. Billiau A., Edy V. G., Sobis H., De Somer P. 1974; Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. II. Evidence for a direct effect on particle release. International Journal of Cancer 14:335–340
   [Google Scholar]
6. De Maeyer-Guignard J., Tovey M. G., Gresser I., De Maeyer E. 1978; Purification of mouse interferon by sequential affinity chromatography on poly (U)- and antibody-agarose columns. Nature, London 271:622–625
   [Google Scholar]
7. Farrel P. J., Sen G. C., Dubois M. F., Ratner L., Slattery E., Lengyel P. 1978; Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proceedings of the National Academy of Sciences of the United States of America 75:5893–5896
   [Google Scholar]
8. Friedman R. M., Chang E. H., Ramseur J. M., Meyers M. W. 1975; Interferon directed inhibition of chronic murine leukemia virus production in cell cultures. Lack of effect on intracellular markers. Journal of Virology 16:569–574
   [Google Scholar]
9. Hovanessian A. G. 1979; Intracellular events in interferon-treated cells. Differentiation 15:139–151
   [Google Scholar]
10. Hovanessian A. G., Kerr I. M. 1979; The (2′5′) oligoadenylate (pppA2′p5′A2′p5′A) synthetase and protein kinase(s) from interferon-treated cells. European Journal of Biochemistry 93:515–526
    [Google Scholar]
11. Hovanessian A. G., Brown R. E., Kerr I. M. 1977; Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature, London 268:537–540
    [Google Scholar]
12. Hovanessian A. G., Wood J., Meurs E., Montagnier L. 1979; Increased nuclear activity in cells treated with pppA2′p5′A2′p5′A. Proceedings of the National Academy of Sciences of the United States of America 76:3261–3265
    [Google Scholar]
13. Hovanessian A. G., Meurs E., Montagnier L. 1980; Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2–5 A synthetase and protein kinase in three different types of murine cells. Journal of Interferon Research (in press)
    [Google Scholar]
14. Kerr I. M., Brown R. E. 1978; pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesised with an enzyme fraction from interferon-treated cells. Proceedings of the National Academy of Sciences of the United States of America 75:256–260
    [Google Scholar]
15. Klein G., Vilcek J. 1980; Attempts to induce interferon production in human lymphoma lines and their hybrids. Journal of General Virology 46:111–117
    [Google Scholar]
16. Lebleu B., Sen G. C., Shaila S., Cabrer B., Lengyel P. 1976; Interferon, dsRNA and protein phosphorylation. Proceedings of the National Academy of Sciences of the United States of America 73:3107–3110
    [Google Scholar]
17. Pitha P. M., Rowe W. P., Oxman M. N. 1976; Effect of interferon on exogenous, endogenous and chronic murine leukemia virus infection. Virology 70:324–338
    [Google Scholar]
18. Pitha P. M., Fernie B., Maldarelu F., Hattman T., Wivel N. A. 1980; Effect of interferon on mouse leukemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon. Journal of General Virology 46:97–110
    [Google Scholar]
19. Roberts W. K., Hovanessian A. G., Brown R. E., Clemens M. J., Kerr I. M. 1976; Interferon-mediated protein kinase and low-molecular weight inhibitor of protein synthesis. Nature, London 264:477–480
    [Google Scholar]
20. Tovey M. G., Begon-Lours J., Gresser I., Morris A. G. 1977; Marked enhancement of interferon production in 5-bromodeoxyuridine treated human lymphoblastoid cells. Nature, London 267:455–457
    [Google Scholar]
21. Williams B. R. G., Golgher R. R., Kerr I. M. 1979; Activation of a nuclease by pppA2′p5′A2′p5’A in intact cells. FEBS Letters 105:47–52
    [Google Scholar]
22. Zilberstein A., Federman P., Shulman L., Revel M. 1976; Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Letters 68:119–124
    [Google Scholar]